UK 100 (CBOE) (BUK100P.L)

Close: 837.77 (+0.38), Apr 25, 2025
Positive

Low risk

Automatic technical analysis. Long term, Apr 25, 2025

Investors have paid higher prices over time to buy UK 100 (CBOE) and the index is in a rising trend channel in the long term. This signals increasing optimism among investors and indicates continued rise. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 760 points. The index is assessed as technically positive for the long term.

Recommendation one to six quarters: Positive (Score: 93)

Period  
 Vol.bal. Volatility Liquidity +/- %
1 day-0.52%0.00+0.04%
5 days0.001.72%0.00+1.60%
22 days0.004.10%0.00-3.41%
66 days0.006.98%0.00-2.20%

More analyses of UK 100 (CBOE)

chart UK 100 (CBOE) (BUK100P) Candlesticks 22 Days
Candlesticks
chart UK 100 (CBOE) (BUK100P) Short term
Short term: Weak Negative
chart UK 100 (CBOE) (BUK100P) Medium term
Medium term: Hold
chart UK 100 (CBOE) (BUK100P) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

×

Please login here

 
Forgot your password?

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.